中国P站

Obesity; Weight management; Pharmacological interventions; Lifestyle interventions; Digital health; Bariatric surgery; Gut microbiota; Precision nutrition; Cognitive Behavioral Therapy; Intermittent fasting

Introduction

This scientific statement provides comprehensive guidance on the pharmacological management of obesity, emphasizing its role as a chronic disease. It reviews the efficacy and safety of current anti-obesity medications, integrating them into a holistic treatment approach that includes lifestyle interventions. The statement offers clinical recommendations for selecting appropriate medications based on patient comorbidities and individual responses, highlighting the evolving landscape of obesity treatment with new therapeutic options [1].

This systematic review explores the intricate relationship between the gut microbiota composition and its influence on weight management strategies. It summarizes how alterations in the gut microbiome can impact host metabolism, energy extraction, and nutrient absorption, contributing to obesity or facilitating weight loss. The review highlights the potential for targeting the gut microbiota through dietary interventions, probiotics, or prebiotics as a novel approach to prevent and treat obesity, underscoring the personalized nature of these interventions [2].

This systematic review and meta-analysis evaluates the effectiveness of various digital health interventions in promoting weight management among adults. The findings suggest that digital tools, including mobile apps, wearable devices, and online platforms, can be effective in achieving modest but significant weight loss compared to usual care or minimal interventions. The review highlights the potential of these technologies to increase accessibility and adherence to weight loss programs, advocating for their integration into comprehensive obesity treatment strategies, particularly those incorporating personalized feedback and behavioral coaching components [3].

This pivotal clinical trial, SURMOUNT-1, demonstrates the significant efficacy of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, for substantial weight loss in adults with obesity or overweight and weight-related comorbidities, excluding diabetes. Participants receiving tirzepatide achieved remarkable mean weight reductions, with a high proportion reaching over 15% and even 20% body weight loss. The findings establish tirzepatide as a highly potent pharmacological intervention for obesity, surpassing previous anti-obesity medications in terms of magnitude of weight loss, although gastrointestinal side effects were common [4].

This systematic review and network meta-analysis compared the effectiveness of various exercise modes, including aerobic training, resistance training, and combined training, on weight loss in overweight and obese adults. The findings suggest that all exercise modalities can contribute to weight reduction, but combined aerobic and resistance training appears to yield the most significant benefits for overall weight loss and body composition improvements. The study emphasizes the importance of consistent physical activity as a cornerstone of weight management, with tailored approaches based on individual preferences and health conditions [5].

This systematic review and network meta-analysis comprehensively compares the efficacy of various dietary patterns, such as low-carbohydrate, low-fat, Mediterranean, and intermittent fasting, for weight loss and improvements in metabolic parameters in overweight and obese adults. The findings suggest that while multiple dietary approaches can lead to significant weight loss, adherence and sustainability are key factors. The study indicates certain dietary patterns may offer superior benefits for specific metabolic markers, emphasizing the need for individualized dietary recommendations that consider patient preferences, cultural backgrounds, and long-term feasibility for successful weight management [6].

This long-term study investigates the outcomes of bariatric surgery in adolescents with severe obesity, providing crucial evidence on its sustained efficacy and safety in this younger population. The results demonstrate significant and durable weight loss, accompanied by substantial improvements in obesity-related comorbidities such as type 2 diabetes, hypertension, and dyslipidemia. While highlighting the benefits, the study also addresses potential long-term complications and nutritional deficiencies, underscoring the necessity for comprehensive postoperative care and lifelong follow-up to optimize outcomes and manage potential risks effectively [7].

This systematic review and meta-analysis investigates the effectiveness of Cognitive Behavioral Therapy (CBT) as an intervention for weight management in individuals with overweight or obesity. The findings suggest that CBT, either standalone or as an adjunct to other weight loss programs, can significantly contribute to sustained weight reduction and improvements in eating behaviors and psychological well-being. The review highlights CBT's role in addressing maladaptive thoughts and behaviors related to food, body image, and self-regulation, making it a valuable component in comprehensive, multidisciplinary approaches to long-term weight management [8].

This review article explores the burgeoning field of precision nutrition in the context of obesity management, advocating for a shift from generalized dietary advice to individualized strategies. It discusses how genetic predispositions, gut microbiome profiles, metabolic responses, and lifestyle factors can be leveraged to tailor nutritional interventions for more effective and sustainable weight loss outcomes. The article highlights the potential of omics technologies and advanced analytical tools to identify unique biological and behavioral phenotypes, paving the way for highly personalized dietary recommendations that optimize metabolic health and prevent weight regain [9].

This systematic review and meta-analysis examines the efficacy of various intermittent fasting (IF) regimens, including alternate-day fasting, 5:2 fasting, and time-restricted eating, for weight loss in adults with overweight or obesity. The findings indicate that IF can lead to modest but clinically significant weight reduction, comparable to continuous energy restriction, and may also improve certain cardiometabolic markers. The review emphasizes the importance of adherence, sustainability, and individualized approaches in selecting and implementing IF protocols, while also noting the need for further research on long-term outcomes and potential adverse effects [10].

Description

The comprehensive management of obesity encompasses a spectrum of interventions, from pharmacological advancements to lifestyle modifications and surgical options. A key area is the pharmacological management of obesity, recognized as a chronic disease [1]. Current anti-obesity medications are reviewed for their efficacy and safety, integrated into holistic treatment plans alongside lifestyle interventions. Clinical recommendations guide medication selection, considering patient comorbidities and individual responses, reflecting an evolving therapeutic landscape with new options emerging [1]. A prime example is the pivotal SURMOUNT-1 clinical trial, which demonstrated the substantial efficacy of tirzepatide, a dual GIP and GLP-1 receptor agonist, for significant weight loss in adults with obesity or overweight, excluding diabetes [4]. This agent achieved remarkable mean weight reductions, with a high percentage of participants losing over 15% to 20% of their body weight, establishing it as a highly potent pharmacological intervention, despite common gastrointestinal side effects [4].

Beyond pharmaceutical solutions, lifestyle interventions remain fundamental. Dietary strategies are extensively studied, with systematic reviews comparing the efficacy of various patterns such as low-carbohydrate, low-fat, Mediterranean, and intermittent fasting for weight loss and metabolic improvements [6, 10]. Findings suggest that while multiple dietary approaches can induce significant weight loss, adherence and sustainability are critical. Certain diets may offer superior benefits for specific metabolic markers, underscoring the need for individualized recommendations based on patient preferences, cultural backgrounds, and long-term feasibility [6]. Intermittent Fasting (IF) regimens, including alternate-day fasting and time-restricted eating, can lead to modest but clinically significant weight reduction comparable to continuous energy restriction, potentially improving cardiometabolic markers, with adherence being crucial [10]. Exercise is another cornerstone, with various modes including aerobic, resistance, and combined training contributing to weight reduction. Combined aerobic and resistance training appears to yield the most significant benefits for overall weight loss and body composition, emphasizing consistent physical activity tailored to individual needs [5].

Behavioral and technological interventions increasingly play a vital role in weight management. Cognitive Behavioral Therapy (CBT) has shown effectiveness, either standalone or as an adjunct, in promoting sustained weight reduction and improving eating behaviors and psychological well-being [8]. CBT addresses maladaptive thoughts related to food, body image, and self-regulation, making it a valuable component in multidisciplinary weight management approaches [8]. Digital health interventions, such as mobile applications, wearable devices, and online platforms, are also effective in achieving modest but significant weight loss compared to usual care [3]. These technologies enhance accessibility and adherence to weight loss programs, particularly when incorporating personalized feedback and behavioral coaching [3]. Furthermore, the intricate relationship between gut microbiota composition and weight management is gaining attention [2]. Alterations in the gut microbiome can influence host metabolism, energy extraction, and nutrient absorption, impacting obesity or facilitating weight loss. Targeting the gut microbiota through dietary interventions, probiotics, or prebiotics represents a novel and personalized approach to prevention and treatment [2].

For severe cases, surgical interventions like bariatric surgery offer profound and lasting benefits. Long-term studies in adolescents with severe obesity demonstrate significant and durable weight loss, alongside substantial improvements in comorbidities such as type 2 diabetes, hypertension, and dyslipidemia [7]. While effective, bariatric surgery necessitates comprehensive postoperative care and lifelong follow-up to manage potential complications and nutritional deficiencies [7]. Looking ahead, precision nutrition is an emerging field in obesity management, moving beyond generalized advice towards individualized strategies [9]. This approach leverages genetic predispositions, gut microbiome profiles, metabolic responses, and lifestyle factors to tailor nutritional interventions. Omics technologies and advanced analytical tools are vital in identifying unique biological and behavioral phenotypes, leading to highly personalized dietary recommendations that optimize metabolic health and prevent weight regain [9]. This integrated perspective suggests that successful weight management increasingly relies on a tailored blend of scientific advancements and personalized care.

Conclusion

The management of obesity involves a diverse range of strategies, spanning pharmacological, lifestyle, and behavioral interventions, recognizing obesity as a chronic disease. Recent scientific statements provide comprehensive guidance on anti-obesity medications, highlighting their efficacy and safety within a holistic treatment framework that includes lifestyle changes and personalized selection based on patient comorbidities [C001]. Notably, clinical trials demonstrate the potent effect of novel agents like tirzepatide, which achieve substantial weight reductions, marking a significant advancement in pharmacological interventions [C004]. Beyond medication, dietary approaches are crucial. Various patterns, including low-carbohydrate, Mediterranean, and intermittent fasting, prove effective for weight loss and improving metabolic parameters, with emphasis placed on adherence, sustainability, and individualized dietary recommendations [C006, C010]. Physical activity, particularly a combination of aerobic and resistance training, is recognized as fundamental for improving body composition and achieving weight reduction [C005]. Digital health tools, such as mobile apps and wearables, enhance accessibility and adherence to weight loss programs through personalized feedback and behavioral coaching [C003]. Emerging research also explores the intricate link between gut microbiota and weight, suggesting personalized dietary or probiotic interventions could modulate metabolism and nutrient absorption [C002]. Cognitive Behavioral Therapy (CBT) offers a valuable component by addressing maladaptive eating behaviors and enhancing psychological well-being for sustained weight management [C008]. For adolescents with severe obesity, bariatric surgery shows sustained efficacy in achieving weight loss and resolving comorbidities, though it necessitates careful long-term follow-up [C007]. The future points towards precision nutrition, utilizing genetic and metabolic profiles to tailor individualized dietary strategies for superior and lasting weight control [C009]. This collection of studies collectively underscores the importance of a personalized, integrated approach in tackling the complexities of obesity.

References

1. Michael DJ, Donna HR, Caroline MA (2023) .J Clin Endocrinol Metab 108:225-244.

   , ,

2. Othman AB, Mohammed FA, Naji MA (2021) .Nutrients 13:1717.

   , ,

3. Yufei Z, Sha C, Li Z (2022) .EClinicalMedicine 50:101377.

   , ,

4. Ania MJ, Louis JA, Nina NA (2022) .N Engl J Med 387:205-216.

   , ,

5. Ziqi W, Sha C, Xin Q (2022) .Front Public Health 10:955427.

   , ,

6. Shulin C, Yaqiong C, Xiaolong L (2023) .Am J Clin Nutr 118:815-827.

   , ,

7. Thomas HI, Rhiannon YC, Lydia B (2021) .N Engl J Med 384:989-1002.

   , ,

8. Jie L, Yan W, Huijuan C (2023) .Psychol Med 53:3655-3665.

   , ,

9. Luigi B, Domenica L, Estefania F (2023) .Nutrients 15:543.

   , ,

10. Xin L, Shuaibing P, Shuxuan Y (2023) .Nutrients 15:746.

    , ,